You are here

Pharmaceuticals and Healthcare

The business of vital innovation

Share

The pharmaceutical and healthcare sector is one of the world’s most vital and innovative.

Against a backdrop of technological change and an increasing and aging population, we partner with our clients to help them achieve their goals, capitalise on opportunities and navigate uncertainty.

Combining deep scientific, technical and strategic knowledge we help our clients by providing the commercial nous, experience and range of services that only a large international professional services firm can offer, to anticipate and deliver innovative and value-enhancing solutions.

Recent Experience

Indivior plc

in connection with the Relationship Agreement and settlement reached with the Company’s largest shareholder, the activist investor Scopia Management

Parkinson's UK

on its acquisition of assets relating to the research, development, manufacture and marketing of glial-cell line-derived neurotrophic factor (GDNF), a potentially disease-modifying treatment for Parkinson's disease

SK Holdings

on its acquisition of Yposkesi, a French market leader in gene therapy and viral vector manufacturing

Acacia Research Corporation

on its entry into an agreement with Link Fund Solutions Limited to purchase shares in up to 19 public and private life sciences companies from the LF Equity Income Fund for up to £223.9 million.

FederFARMACO

a company representing pharmaceutical wholesalers, on regulatory affairs and intellectual property matters

Mirnagreen

 in relation to the launch and correct classification of new products based on a disruptive technology for extracting microRNA from plants, including advising on strategy to mitigate risks related to a misclassification under the contiguous categories of medicinal products, novel food and food supplements

Insights and updates

19th August 2022
On 18 August 2022, the Commonwealth Government released draft legislation proposing five-fold increases in the...
25th March 2022
Last week, a Full Court of the Federal Court of Australia handed down two unanimous...
18th November 2021
‘Cyber-ransoms’ are on the rise, and with new cyber tactics and ways of working, the...
24th June 2021
The Federal Court has rejected the Australian Patent Office’s historical approach to patent term extension...

Related news and deals

01 September 2022

Herbert Smith Freehills advises sponsors on Biocytogen Pharmaceuticals' Hong Kong IPO 史密夫斐尔律师事务所作为保荐人律师为百奥赛图香港上市提供法律服务

06 July 2022

Herbert Smith Freehills Kewei advises Sanofi on US$15 million cornerstone investment in ClouDr 科伟史密夫斐尔联营办公室为赛诺菲完成1500万美元基石投资提供法律服务

18 May 2022

Herbert Smith Freehills advises sponsors on Yunkang Group's Hong Kong IPO / 史密夫斐尔律师事务所作为保荐人律师为云康集团香港上市提供法律服务